EDWARDS LIFESCIENCES CORPORATION |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 87.26 USD | +0.43% |
|
+0.08% | +14.24% |
| 03:19pm | Sector Update: Health Care Stocks Steady Premarket Monday | MT |
| 01:13pm | Becton, Dickinson to Acquire Edwards Lifesciences' Critical Care Product Division for $4.2 Billion in Cash | MT |
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Calendar
04/06/2024
- William Blair Growth Stock Conference
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
32
Last Close Price
86.89
USD
Average target price
96.55
USD
Spread / Average Target
+11.12%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +14.24% | 5.24TCr | |
| +6.30% | 22TCr | |
| +11.74% | 19TCr | |
| +18.51% | 14TCr | |
| +29.79% | 11TCr | |
| +0.65% | 6.46TCr | |
| +2.06% | 4.85TCr | |
| -5.04% | 3.8TCr | |
| -0.89% | 3.56TCr | |
| +19.08% | 3.03TCr |
- Stock Market
- Equities
- EW Stock
- News Edwards Lifesciences Corporation
- Edwards Lifesciences Guides For Q1 EPS of $0.62-$$0.66 on Sales of $1.53-$1.61 Billion, vs CIQ Analyst Consensus of $0.67/Share on Sales of $1.56 Billion
